aTyr Pharma Inc. (ATYR)
NASDAQ: ATYR
· Real-Time Price · USD
4.90
-0.09 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
4.93
0.61%
After-hours: Aug 15, 2025, 07:48 PM EDT
aTyr Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -19.53M | -14.88M | -14.97M | -17.26M | -16.31M | -15.49M | -14.76M | -11.34M | -12.34M | -11.95M | -7.52M | -13.24M | -12.42M | -12.15M | -8.56M | -7.67M | -10.39M | -7.16M |
Depreciation & Amortization | 387K | 383K | -1K | 388K | 383K | 770K | 407K | 993K | 586K | 755K | 697K | 414K | 286K | 298K | 320K | 329K | 358K | 297K |
Stock-Based Compensation | 1.3M | 1.18M | 770K | 752K | 727K | 740K | 659K | 664K | 658K | 619K | 605K | 615K | n/a | n/a | n/a | n/a | 398K | 360K |
Other Working Capital | -893K | 2M | 700K | 1.53M | -395K | -7.82M | 589K | 1.25M | -726K | 1.58M | 6.01M | -2.02M | -588K | 947K | -362K | -3.06M | 1.89M | -1.33M |
Other Non-Cash Items | -458K | -523K | -553K | -611K | -735K | -807K | -887K | -979K | 222K | -7.12M | 12.1M | -264K | -1.61M | 935K | 1.41M | 2.69M | 55K | 51K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.4M | -1.58M | 1.62M | 3.57M | -4.52M | -7.59M | 3.52M | 1.1M | -17K | 10.41M | -4.12M | -190K | 2.3M | 1.17M | -488K | -4.61M | 1.89M | 620K |
Operating Cash Flow | -13.89M | -15.42M | -13.13M | -13.16M | -20.45M | -22.38M | -11.06M | -9.56M | -12.01M | -590K | -10.37M | -12.28M | -9.12M | -10.12M | -8.09M | -11.47M | -7.69M | -5.83M |
Capital Expenditures | -9K | n/a | -25K | -15K | -8K | -17K | -17K | -557K | -2.4M | -1.25M | -1.12M | -426K | -53K | -43K | -18K | -61K | -96K | -17K |
Cash Acquisitions | n/a | n/a | 7K | n/a | n/a | n/a | n/a | n/a | 15K | n/a | n/a | 10K | n/a | 169K | 50K | n/a | n/a | n/a |
Purchase of Investments | -18.16M | -23.11M | -26.07M | -2.91M | -18.79M | -21.34M | -9.66M | -28.61M | -22.48M | -46.23M | -24.99M | -5.95M | -11.18M | n/a | -57.7M | -28.79M | -14.35M | -25.68M |
Sales Maturities Of Investments | 20.48M | 18.68M | 20M | 20.87M | 25.52M | 20M | 27.5M | 33.55M | 20.7M | 9.3M | 28.11M | 27.01M | 21.2M | 14.5M | 8.31M | 14M | 10.47M | 2.3M |
Other Investing Acitivies | 981K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.76M | -36.93M | 3.12M | 21.07M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 3.3M | -4.42M | -6.08M | 17.95M | 6.73M | -1.36M | 17.82M | 4.38M | -4.16M | -38.17M | 2M | 20.65M | 9.97M | 14.63M | -49.35M | -14.85M | -3.97M | -23.39M |
Debt Repayment | -133K | -131K | -128K | -125K | -123K | -121K | -115K | -108K | -105K | -66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 61K | n/a | 39K | n/a | 40K | n/a | 65K | n/a | 918K | n/a | 5K | 1K | 9K | 58K | 6K | n/a |
Financial Cash Flow | 17.9M | 18.63M | 18.84M | -105K | 13.4M | 7.73M | 6.03M | 2.68M | 8.02M | 49.5M | 918K | 3.01M | 39K | 1.48M | 28K | 83.87M | 1.27M | 24.86M |
Net Cash Flow | 7.3M | -1.21M | -378K | 4.68M | -321K | -15.74M | 12.76M | -2.53M | -8.38M | 10.71M | -8.38M | 9.88M | 160K | 5.99M | -57.41M | 57.55M | -10.39M | -4.37M |
Free Cash Flow | -13.9M | -15.42M | -13.16M | -13.17M | -20.46M | -22.4M | -11.08M | -10.12M | -14.4M | -1.84M | -11.49M | -12.71M | -9.17M | -10.16M | -8.1M | -11.53M | -7.79M | -5.84M |